rethinkTHC Search
Menu
Study breakdown

Psychedelic experiences produced both more positive and more negative effects than cannabis experiences

Cross SectionalModerate evidence
The takeaway

In demographically representative samples, psychedelic experiences were associated with greater challenging effects and persisting negatives than cannabis, but also greater positive acute and lasting effects, presenting a more complex risk-benefit profile.

Psychedelic researchers, cannabis researchers, policymakers comparing substance risk profiles, and clinicians counseling patients about substance use.

What the researchers found

Psychedelic experiences had greater acute challenging effects and persisting negative effects compared to cannabis, but also greater positive acute and persisting effects. Common predictors of outcomes included dose level, presence of others, religiosity, and personality traits, though these explained only small amounts of variance.

Why it matters

As psychedelics gain therapeutic attention, comparing their risk-benefit profile to the most commonly used illicit substance provides practical context. Cannabis serves as a useful benchmark because most adults have some reference point for it.

The numbers in context

Study 1: n=743 (between-subjects). Study 2: n=514 (within-subjects). Psychedelics: greater positive AND negative acute effects. Greater persisting positive AND negative effects. Predictors explained small variance.

How the study worked

Two studies using opt-in panel sampling reflecting US Census demographics: a between-subjects design (n=743) comparing psychedelic vs cannabis experiences, and a within-subjects design (n=514) in dual-experienced users.

What this study cannot tell us

Retrospective self-report of first or most memorable experiences is subject to recall bias and narrative construction. Panel sampling, while better than social media convenience sampling, may not reach the most marginalized users.

How to read the evidence

Improved sampling over previous psychedelic surveys, but retrospective self-report and comparing different substance classes limits strength.

When this study was published

2025 publication.

The bigger picture

The finding that psychedelics amplify both positive and negative experiences compared to cannabis challenges simple narratives about either substance. It suggests psychedelics are not simply "more dangerous" or "more therapeutic" but operate at a higher intensity on both axes.

Questions still open

  • Can the factors predicting negative psychedelic experiences be used to improve clinical screening?
  • Does the simultaneous increase in both positive and negative effects reflect a single intensity dimension?

Common questions

Why compare psychedelics to cannabis?
Cannabis is the most commonly used illicit substance and provides a familiar reference point. Unlike previous psychedelic surveys that selected for extreme experiences, this study compared both substances in representative samples.
What predicted negative psychedelic experiences?
Higher doses, being alone, certain personality traits, and lower religiosity were modestly associated with more negative effects, though these factors explained only small amounts of the variation in outcomes.

Read the original research

Psychedelic risks and benefits: A cross-sectional survey study.

Journal of psychopharmacology (Oxford, England), 39(5), 436-452

Citation

Goldy, Sean P; Du, Benjamin A; Rohde, Julia S; Nayak, Sandeep M; Strickland, Justin C; Ehrenkranz, Rebecca; Levine, Michael; Barrett, Frederick S; Yaden, David B. (2025). Psychedelic risks and benefits: A cross-sectional survey study.. Journal of psychopharmacology (Oxford, England), 39(5), 436-452. https://doi.org/10.1177/02698811241292951

Explore the wider topic